The polymorphism nt 76 in exon 2 of SC is more frequent in Whites than in Blacks by Fuchisawa, Akiko et al.
IMMUNOHEMATOLOGY, Volume 25, Number 1, 200918
The polymorphism nt 76 in exon 2 of SC is 
more frequent in Whites than in Blacks
A. Fuchisawa, C. Lomas-Francis, K. Hue-Roye, and M.E. Reid
Table 1. Primer sequences and expected products*
Primer 
name




ScI2F cagcccgcttgtgctgtctc Wild type: 121 
bp, 40bp





*Primer sequences are written in lowercase letters because they are located
in the introns.
Exon 2 (161 bp)
Exon 3 (149 bp) Not applicable
Exon 4 (188 bp) Not applicable
The Scianna blood group system comprises seven antigens en-
coded by alternative forms of SC. The SC gene also has two poly-
morphisms in the leader sequence, at nucleotides 54 (C/T, silent) 
and 76 (C/T, 26His/Tyr) in exon 2, which are not involved in ex-
pression of blood group antigens. The nucleotide change at posi-
tion 76 has an NlaIII restriction enzyme site; thus, DNA samples 
from 100 Caucasians and 100 African Americans were analyzed 
for the SC nucleotide 76 change. DNA from Caucasian and African 
American donors was tested by polymerase chain reaction (PCR)-
restriction fragment length polymorphism (RFLP) using the re-
striction enzyme NlaIII. In selected samples, sequencing of exon 
2 was performed. PCR-RFLP results for samples from 100 donors 
(mostly Caucasian) and 100 African American donors (400 alleles) 
showed the nucleotide 76T variant had a prevalence of 25 percent 
in Whites and 5 percent in African Americans. In 11 samples (2 
C/C, 3 C/T, and 6 T/T) sequencing of exon 2 confirmed the presence 
of the expected nucleotides at position 76. The allele frequency 
in Caucasians was 0.75 for nt76C and 0.25 for nt76T. In African 
Americans, the frequencies were, respectively, 0.95 and 0.05. 
Immunohematology 2009;25:18–19.
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The Scianna (Sc) blood group system (ISBT 013) com-prises seven antigens that are encoded by alternative forms of SC (or ERMAP).1,2 Sc1 and Sc2 have an an-
tithetical relationship and are, respectively, high- and low-
prevalence antigens. Sc3 is expressed on all RBCs except 
those from individuals with the Sc
null
 phenotype. Sc4 (Rd) 
is a low-prevalence antigen, and Sc5 (STAR)3, Sc6 (SCER), 
and Sc7 (SCAN)2 are high-prevalence antigens whose an-
tithetical antigens have not been reported. The molecular 
bases associated with the antigens are known. In addition, 
two nucleotide (nt) polymorphisms (nt54C>T, a silent 
change; and nt76C>T, predicted to encode His26Tyr) are 
in the sequence of nucleotides that encode the leader se-
quence of the SC glycoprotein, which is not present on the 
RBC.1,2 We report the analysis of DNA samples from 100 
donors (mostly Caucasians) and 100 African Americans for 
the prevalence of the SC nt76 change.
Materials and Methods
Blood samples
Samples from 100 random (mostly Caucasian) donors 
and 100 donors who had either the homozygous mutated 
FY-GATA box (n = 20) or self-identified as being African 
American (n = 80) were obtained under Institutional Re-
view Board–approved protocols and tested.
Sequence analysis of genomic DNA for SC
Genomic DNA was isolated from whole blood (QIAamp 
DNA Blood Mini Kit, QIAGEN, Inc., Valencia, CA). The re-
gions of SC that included and flanked exons 2, 3, and 4 were 
amplified separately using the oligonucleotide primers list-
ed in Table 1. The primers were synthesized by Life Tech-
nologies, Inc. (Gaithersburg, MD). Five microliters of DNA 
per reaction were amplified by 5 U of Taq DNA polymerase 
(HotStarTaq, QIAGEN Inc.) in a 50-μL reaction mixture 
containing 2.5 mM MgCl
2
, 1× PCR buffer, 0.2 mM dNTPs, 
and 100 ng of forward and reverse primer. Amplification 
was achieved during 35 cycles with a final extension time 
of 10 minutes. The PCR was performed using 62°C as the 
annealing temperature. The PCR products were sequenced 
in the Laboratory of Microchemistry at the New York Blood 
Center using an ABI 373XL sequencer (Applied Biosystems, 
Inc., Foster City, CA), and ABI Big Dye reagents with BD 
Half-Term (GenPak, Stony Brook, NY). The PCR products 
were directly sequenced using the forward and reverse 
primers that were used for PCR amplification.
Original Report
PCR-RFLP analysis
One hundred DNA samples mostly from Caucasians and 
100 from African Americans were amplified for the region 
of SC that included and flanked exon 2, using the ScI2F and 
ScI2R oligonucleotide primer pair (Table 1). The PCR prod-
ucts (161 bp) were digested using the restriction enzyme 
NlaIII. The restriction enzyme site of NlaIII is present in 
the wild-type DNA with nt 76C and ablated in the variant nt 
76T. The expected sizes for bands in the wild type were 121 
IMMUNOHEMATOLOGY, Volume 25, Number 1, 2009 19
and 40 bp, and for the variant, 161 bp (uncut). There is no 
restriction site to distinguish the wild-type nt54C from the 
variant nt54T.
Results
PCR-RFLP analysis on random samples
PCR-RFLP analysis for nt76C/T in the 100 random 
(mostly Caucasian) donors resulted in 62 samples that were 
consistent with the expected digestion pattern of the wild 
type (76C), 11 samples that were consistent with the expect-
ed digestion pattern for homozygosity for the variant (76T), 
and 27 that were consistent with the expected digestion pat-
tern for heterozygosity for the variant (76C/T). For the 100 
samples from African American donors, 91 were consistent 
with the expected digestion pattern of the wild type (76C), 
1 was consistent with the expected digestion pattern for 
homozygosity for the variant (76T), and 8 were consistent 
with the expected digestion pattern for heterozygosity for 
the variant (76C/T). These results are summarized in Table 2.
Sequence analysis of the random samples
Eleven of the random donor samples, which demon-
strated either a homozygous change (n = 6), heterozygous 
change (n = 3), or wild type (n = 2), were sent for direct se-
quencing. Sequence analysis of the six samples homozygous 
for the variant were confirmed to be nt76T and also shown 
to be homozygous for the variant nt54T. Sequence analysis 
of the three samples heterozygous for the variant selected 
on the basis of the PCR-RFLP assay were confirmed to be 
heterozygous nt76C/T and also shown to be heterozygous 
for nt54C/T. Sequence analysis of the two wild-type sam-
ples selected on the basis of the PCR-RFLP assay were con-
firmed to be homozygous wild type for nt76C and shown to 
be also homozygous wild type for nt54C.
Discussion
The SC nt76C>T change (His26Try) is located in the 
sequence of nucleotides that encode the leader sequence, 
which is cleaved and not present in the RBC-bound ER-
MAP. The SC nt54C>T silent change is also in this sequence 
but does not give rise to or ablate a restriction enzyme site. 
In the 11 samples analyzed by sequencing, either both nt54 
and nt76 changes were present or neither was present. 
Whether these are linked polymorphisms in the heterozy-
gotes requires plasmid cloning of the PCR products to eval-
uate single sequences. In our study, the allele frequency in 
Caucasians was 0.75 for 76C and 0.25 for nt76T. In African 
Americans, the frequencies were 0.95 and 0.05, respectively.
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Table 2. Results of PCR-RFLP using NlaIII











V = variant; W = wild type.
